Prediction of Atrial Fibrillation Using Polygenic Risk Score
NCT: NCT07641582 · RECRUITING
Brief Summary
The goal of this clinical trial is to learn whether a genetic risk score can help identify undiagnosed atrial fibrillation (AF) in adults who may have it. AF is an irregular heartbeat that raises the risk of stroke if not treated early. The main questions it aims to answer are: Can a polygenic risk score (PRS) - a score based on a person's genes - identify who is more likely to have AF? Does combining PRS with a person's medical history predict AF better than using medical history alone? Participants will: Wear a continuous ECG patch for 7 days to record heart rhythm Give a blood sample for genetic testing to calculate their PRS Use a six-lead handheld ECG device (HATIV® P30, VUNO Inc., Seoul, Republic of Korea) to check their own heart rhythm at home once or twice a week for 1 year Visit the clinic 5 times over 1 year Researchers will use the genetic and clinical information collected to build a scoring system that predicts who is at risk for AF.
Frequently Asked Questions
What is Prediction of Atrial Fibrillation Using Polygenic Risk Score?
Prediction of Atrial Fibrillation Using Polygenic Risk Score is a clinical trial registered under NCT07641582. Current status: RECRUITING.
What is the status of NCT07641582?
The current status of NCT07641582 (Prediction of Atrial Fibrillation Using Polygenic Risk Score) is: RECRUITING.
When did Prediction of Atrial Fibrillation Using Polygenic Risk Score start?
Prediction of Atrial Fibrillation Using Polygenic Risk Score started on 2024-11-19.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.